Australien - Englisch - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - olanzapine, quantity: 20 mg - tablet, film coated - excipient ingredients: crospovidone; magnesium stearate; lactose monohydrate; purified talc; microcrystalline cellulose; hyprolose; titanium dioxide; xanthan gum; polyvinyl alcohol; lecithin; iron oxide yellow; iron oxide red; iron oxide black - for the treatment of schizophrenia and related psychoses. ,alone or in combination with lithium or valproate, it is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. ,for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - olanzapine, quantity: 2.5 mg - tablet, film coated - excipient ingredients: hyprolose; purified talc; crospovidone; lactose monohydrate; microcrystalline cellulose; magnesium stearate; titanium dioxide; xanthan gum; polyvinyl alcohol; lecithin - for the treatment of schizophrenia and related psychoses. ,alone or in combination with lithium or valproate, it is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. ,for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - olanzapine, quantity: 10 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose; hyprolose; microcrystalline cellulose - apo-olanzapine? treatment of schizophrenia and related psychoses. ? short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar i disorder. ? preventing recurrence of manic, mixed or depressive episodes in bipolar 1 disorder.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - olanzapine, quantity: 7.5 mg - tablet, uncoated - excipient ingredients: hyprolose; lactose; microcrystalline cellulose; magnesium stearate - - treatment of schizophrenia and related psychoses. - short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar i disorder.. - preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - olanzapine, quantity: 10 mg - tablet, uncoated - excipient ingredients: magnesium stearate; lactose; hyprolose; microcrystalline cellulose - - treatment of schizophrenia and related psychoses. - short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar i disorder.. - preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - olanzapine, quantity: 2.5 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose; hyprolose; magnesium stearate - - treatment of schizophrenia and related psychoses. - short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar i disorder.. - preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - olanzapine, quantity: 5 mg - tablet, uncoated - excipient ingredients: magnesium stearate; microcrystalline cellulose; lactose; hyprolose - - treatment of schizophrenia and related psychoses. - short-term treatment, alone or in combination with lithium or valproate, of acute manic episodes associated with bipolar i disorder.. - preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - olanzapine, quantity: 5 mg - tablet, film coated - excipient ingredients: crospovidone; pregelatinised maize starch; maize starch; lactose monohydrate; magnesium stearate; titanium dioxide; purified talc; xanthan gum; polyvinyl alcohol; lecithin - olanzapine is indicated for the treatment of schizophrenia and related psychoses. olanzapine alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. olanzapine is indicated for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - olanzapine, quantity: 7.5 mg - tablet, film coated - excipient ingredients: crospovidone; magnesium stearate; pregelatinised maize starch; lactose monohydrate; maize starch; titanium dioxide; purified talc; xanthan gum; polyvinyl alcohol; lecithin - olanzapine is indicated for the treatment of schizophrenia and related psychoses. olanzapine alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. olanzapine is indicated for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - olanzapine, quantity: 2.5 mg - tablet, film coated - excipient ingredients: crospovidone; magnesium stearate; pregelatinised maize starch; lactose monohydrate; maize starch; titanium dioxide; purified talc; xanthan gum; polyvinyl alcohol; lecithin - olanzapine is indicated for the treatment of schizophrenia and related psychoses. olanzapine alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. olanzapine is indicated for preventing recurrence of manic, mixed or depressive episodes in bipolar i disorder.